Summit for vaccine internationalism begins

It brings together vaccine manufacturers from more than twenty countries

June 19, 2021 05:27 am | Updated 05:27 am IST - NEW DELHI

The Progressive International’s four-day Summit for vaccine internationalism opened on Friday, with the goal of ending “the pandemic as quickly as possible by securing COVID-19 vaccines for all”. According to a release issued by this global initiative, the summit brings together Global south governments, political leaders, healthcare workers and vaccine manufacturers from more than twenty countries and follows criticism of the G7’s plan by U.N. aid chief Mark Lowcock as “not serious” and lacking “necessary urgency.”

With only 6.2% of the world population fully vaccinated against COVID, the Summit’s participants want to seek to speed up the production, distribution, and delivery of vaccines to the world. The meet hope to consider concrete proposals to pool technology, invoke patent waivers and invest in rapid production.

Representatives from the governments of Argentina, Bolivia, Mexico, Cuba, Venezuela, the Indian State of Kerala and the Kenyan county of Kisumu will be joined by four vaccine manufacturers — Fiocruz, the Brazilian state manufacturer leading Brazil’s vaccination drive, Virchow Laboratories, an Indian manufacturer with a presence in over 100 countries and an annual turnover of $600 million, Biolyse, a Canadian firm seeking voluntary or compulsory licensing agreements and BioFarmaCuba, Cuba’s state manufacturer, noted the release.

The Summit will also be attended by political leaders from around the world, including former leader of the U.K. Labour Party Jeremy Corbyn, former Greek Finance Minister Yanis Varoufakis and leader of the Colombian opposition Gustavo Petro, and representatives from healthcare unions from the U.S., Brazil and India.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.